GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Avantor AVTR · USD

Health Care · US listing · 🇺🇸 United States

Compare

15.91

+2.84%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$6.55bn

FY2016FY2025

Net income

−$530.2m

FY2016FY2025

Free cash flow

$495.0m

FY2016FY2025

Shareholders' equity

$5.57bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$6.55bn$6.78bn$6.97bn$4.91bn$7.39bn$6.39bn$6.04bn$5.86bn$1.25bn$691.3m
Gross profit$2.14bn$2.28bn$2.36bn$2.60bn$2.50bn$2.08bn$1.92bn$1.82bn$432.8m$319.7m
Research and development—————————$19.1m
Operating income−$271.5m$1.07bn$696.4m$1.13bn$972.2m$706.8m$551.8m$413.5m−$259.3m$9.9m
Net income−$530.2m$711.5m$321.1m$686.5m$572.6m$116.6m$37.8m−$86.9m−$112.7m−$42.4m
Diluted earnings per share-0.781.040.471.010.930.200.06-0.18-0.28-0.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$11.79bn$12.11bn$12.97bn$13.46bn$13.90bn$9.91bn$9.77bn$9.91bn$10.45bn$1.14bn
Cash and short-term investments$365.4m$261.9m$262.9m$372.9m$301.7m$286.6m$186.7m$184.7m$185.4m$62.9m
Total liabilities$6.23bn$6.16bn$7.72bn$8.61bn$9.70bn$7.23bn$7.31bn$12.96bn$13.07bn$1.65bn
Debt$3.95bn$4.06bn$5.54bn$6.29bn$7.02bn$4.89bn$5.12bn$6.92bn$7.12bn$1.30bn
Shareholders' equity$5.57bn$5.96bn$5.25bn$4.86bn$4.20bn$2.67bn$2.46bn−$3.05bn−$2.62bn−$374.9m
Shares outstanding679m683m679m677m619m587m582m491m400m491m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$623.8m$840.8m$870.0m$843.6m$953.6m$929.8m$354.0m$200.5m−$167.5m$72.9m
Capital spending−$128.8m−$148.8m−$146.4m−$133.4m−$111.1m−$61.6m−$51.6m−$37.7m−$25.2m−$29.9m
Free cash flow$495.0m$692.0m$723.6m$710.2m$842.5m$868.2m$302.4m$162.8m−$192.7m$43.0m
Dividends paid——−$18.3m−$32.4m−$64.6m−$64.6m−$31.3m−$31.3m−$1.70bn−$158.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$1.69bn$1.58bn$1.66bn$1.62bn$1.68bn$1.58bn$1.69bn$1.71bn
Gross profit$537.0m$500.7m$523.9m$526.5m$554.1m$534.9m$562.9m$564.4m
Operating income—$98.4m$120.8m−$645.3m$125.1m$127.9m$638.1m$123.2m
Net income$38.1m$43.3m$52.4m−$711.8m$64.7m$64.5m$500.4m$57.8m
Diluted earnings per share0.060.060.08-1.050.100.090.730.08
Cash from operations$178.0m$58.0m$152.0m$207.0m$154.0m$109.0m$173.0m$244.0m
Capital spending−$37.0m−$33.0m−$35.0m−$35.0m−$29.0m−$28.0m−$27.0m−$40.0m
Free cash flow$141.0m$25.0m$117.0m$172.0m$125.0m$81.0m$146.0m$204.0m
Total assets$11.60bn$11.66bn$11.79bn$11.68bn$12.78bn$12.33bn$12.11bn$12.84bn
Cash and short-term investments$306.8m$279.3m$365.4m$251.9m$449.4m$315.7m$261.9m$285.3m
Debt$3.70bn$3.82bn$3.95bn$3.86bn$4.24bn$4.11bn$4.06bn$4.92bn
Shareholders' equity$5.63bn$5.59bn$5.57bn$5.57bn$6.29bn$6.10bn$5.96bn$5.55bn

Financial ratios

Data as of 15 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2016FY2015
Gross margin32.7%33.6%33.9%53.0%33.9%32.5%——
Operating margin-4.1%15.8%10.0%23.0%13.1%5.8%——
Net margin-8.1%10.5%4.6%14.0%7.8%1.8%——
Return on equity-9.5%11.9%6.1%14.1%13.6%4.4%——
Return on assets-4.5%5.9%2.5%5.1%4.1%1.2%——
Free cash flow yield7.0%9.2%9.5%9.2%10.9%10.7%——
Revenue growth-3.4%-2.6%41.9%-33.5%15.5%5.8%——
Earnings growth-174.5%121.6%-53.2%19.9%391.1%208.5%——
Current ratio1.78x1.07x1.61x1.60x1.71x1.80x——
Debt to equity0.71x0.68x1.05x1.29x1.67x1.83x——
Equity ratio47.2%49.2%40.5%36.1%30.2%27.0%——
Interest coverage-1.60x4.90x2.44x4.25x4.46x1.20x——
R&D as a share of sales——————2.8%3.4%
Buybacks as a share of market value0.5%-0.5%-0.3%-9.4%-5.4%-0.9%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.1%0.5%26.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.1%37.2%35.8%35.0%
Operating margin6.0%10.4%11.0%9.5%
Net margin1.4%4.7%4.8%3.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-14.720.248.320.845.5141.7279.5
Price to sales1.22.12.22.93.52.61.8

Market value over time

31 May 2019 to 14 Oct 2026, in USD

$2.33bn$10.63bn

Share price return

Finished calendar years

2025202420232022202120202019
Return-48%-9%14%-49%45%52%24%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.